Alumis (ALMS) Enterprise Value (2023 - 2026)
Alumis (ALMS) posted quarterly Enterprise Value of -$308.5 million for Q4 2025, down 7.02% year-over-year from -$331.8 million in Q4 2024, and up 18.33% quarter-over-quarter from -$377.7 million in Q3 2025.
Alumis (ALMS) Enterprise Value (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported Enterprise Value for 3 consecutive years, with -$308.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Enterprise Value fell 7.02% year-over-year to -$308.5 million; the TTM figure through Dec 2025 stood at -$308.5 million (down 7.02% YoY), while the FY2025 annual figure was -$308.5 million, down 7.02% from the prior year.
- Enterprise Value advanced to -$308.5 million in Q4 2025 per ALMS's latest filing, from -$377.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$49.0 million in Q4 2023 and bottomed at -$377.7 million in Q3 2025.
- Historically, Enterprise Value has averaged -$195.2 million across 3 years, with a median of -$155.2 million in 2024.
- Annual changes were most pronounced in 2024 — Enterprise Value sank 566.97% — and 2025, when it increased 2.0%.
- Alumis' Enterprise Value stood at -$49.0 million in 2023, then plunged by 488.87% to -$288.3 million in 2024, then retreated by 7.02% to -$308.5 million in 2025.
- Business Quant data shows ALMS's Enterprise Value at -$308.5 million in Q4 2025, -$377.7 million in Q3 2025, and -$152.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.32 Bn | 132.47 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 63.35 Bn | 58.16 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 63.15 Bn | 58.01 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.96 Bn | 36.86 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Royalty Pharma | 27.67 Bn | 26.83 Bn | - | 2.12 Bn |
| 8 | BioNTech SE | 27.52 Bn | 9.13 Bn | 668.28 Mn | -18.39 Bn |
| 9 | Insmed | 26.98 Bn | 25.82 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Alumis | 3.06 Bn | 2.56 Bn | - | -502.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -502.29 Mn |
| Dec 31, 2025 | -308.50 Mn |
| Sep 30, 2025 | -377.72 Mn |
| Jun 30, 2025 | -152.12 Mn |
| Mar 31, 2025 | -208.75 Mn |
| Dec 31, 2024 | -288.26 Mn |
| Sep 30, 2024 | -361.87 Mn |
| Jun 30, 2024 | -155.22 Mn |
| Mar 31, 2024 | -112.07 Mn |
| Dec 31, 2023 | -48.95 Mn |
| Sep 30, 2023 | -54.26 Mn |
| Jun 30, 2023 | -79.77 Mn |